JP2010513360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513360A5 JP2010513360A5 JP2009541912A JP2009541912A JP2010513360A5 JP 2010513360 A5 JP2010513360 A5 JP 2010513360A5 JP 2009541912 A JP2009541912 A JP 2009541912A JP 2009541912 A JP2009541912 A JP 2009541912A JP 2010513360 A5 JP2010513360 A5 JP 2010513360A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- liver disease
- preparation according
- food
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YKGCBLWILMDSAV-GOSISDBHSA-N Isoxanthohumol Natural products O(C)c1c2C(=O)C[C@H](c3ccc(O)cc3)Oc2c(C/C=C(\C)/C)c(O)c1 YKGCBLWILMDSAV-GOSISDBHSA-N 0.000 claims 6
- 208000019423 liver disease Diseases 0.000 claims 6
- 239000013543 active substance Substances 0.000 claims 5
- FUSADYLVRMROPL-UHFFFAOYSA-N demethylxanthohumol Natural products CC(C)=CCC1=C(O)C=C(O)C(C(=O)C=CC=2C=CC(O)=CC=2)=C1O FUSADYLVRMROPL-UHFFFAOYSA-N 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- YKGCBLWILMDSAV-SFHVURJKSA-N isoxanthohumol Chemical compound C1([C@H]2OC=3C(CC=C(C)C)=C(O)C=C(C=3C(=O)C2)OC)=CC=C(O)C=C1 YKGCBLWILMDSAV-SFHVURJKSA-N 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- ORXQGKIUCDPEAJ-YRNVUSSQSA-N xanthohumol Chemical compound COC1=CC(O)=C(CC=C(C)C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 ORXQGKIUCDPEAJ-YRNVUSSQSA-N 0.000 claims 3
- UVBDKJHYMQEAQV-UHFFFAOYSA-N xanthohumol Natural products OC1=C(CC=C(C)C)C(OC)=CC(OC)=C1C(=O)C=CC1=CC=C(O)C=C1 UVBDKJHYMQEAQV-UHFFFAOYSA-N 0.000 claims 3
- 235000008209 xanthohumol Nutrition 0.000 claims 3
- 102000003712 Complement factor B Human genes 0.000 claims 2
- 108090000056 Complement factor B Proteins 0.000 claims 2
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 206010019799 Hepatitis viral Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 201000001862 viral hepatitis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006062264A DE102006062264A1 (de) | 2006-12-22 | 2006-12-22 | Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen |
| DE102006062264.2 | 2006-12-22 | ||
| PCT/EP2007/011358 WO2008077618A1 (de) | 2006-12-22 | 2007-12-21 | Verwendung von xanthohumol bzw. isoxanthohumol als wirkstoff zur vorbeugung und/oder bekämpfung von lebererkrankungen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010513360A JP2010513360A (ja) | 2010-04-30 |
| JP2010513360A5 true JP2010513360A5 (enExample) | 2011-01-13 |
| JP5513126B2 JP5513126B2 (ja) | 2014-06-04 |
Family
ID=39186950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009541912A Expired - Fee Related JP5513126B2 (ja) | 2006-12-22 | 2007-12-21 | 肝疾患を予防および／または制御するための、キサントフモールまたはイソキサントフモールの活性物質としての使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100029757A1 (enExample) |
| EP (1) | EP2120906B1 (enExample) |
| JP (1) | JP5513126B2 (enExample) |
| CA (1) | CA2672155C (enExample) |
| DE (1) | DE102006062264A1 (enExample) |
| RU (1) | RU2454996C2 (enExample) |
| WO (1) | WO2008077618A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10722575B2 (en) | 2009-11-26 | 2020-07-28 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| AU2010323066B2 (en) * | 2009-11-26 | 2014-12-11 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| US9221751B2 (en) | 2009-11-26 | 2015-12-29 | Genfit | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders |
| WO2013191903A1 (en) | 2012-06-18 | 2013-12-27 | 3M Innovative Properties Company | Powder composition for air polishing the surface of hard dental tissue |
| EP2877167B1 (en) * | 2012-07-26 | 2020-07-15 | Arcaini, Antonio | Uses of compositions containing a roasted extract and xanthohumol |
| EP2742897A1 (en) | 2012-12-17 | 2014-06-18 | 3M Innovative Properties Company | Nozzle head, hand piece and powder jet device for applying a dental material |
| WO2014099490A2 (en) | 2012-12-17 | 2014-06-26 | 3M Innovative Properties Company | Device for dispensing a dental material with locking mechanism |
| EP2742898A1 (en) | 2012-12-17 | 2014-06-18 | 3M Innovative Properties Company | Powder jet device for dispensing a dental material |
| WO2017001020A1 (de) | 2015-07-02 | 2017-01-05 | Flaxan Gmbh & Co. Kg | Substanz auf hopfenbasis sowie verwendung der substanz |
| CN110087492A (zh) * | 2016-12-20 | 2019-08-02 | 三得利控股株式会社 | 含有异黄腐酚的脂质代谢促进用组合物 |
| RU2752078C1 (ru) | 2017-07-11 | 2021-07-22 | Акванова Аг | Солюбилизат с куркумином и при необходимости по меньшей мере с одним другим активным веществом |
| EP3820527B1 (de) * | 2018-07-11 | 2023-08-23 | Aquanova AG | Xanthohumol-solubilisat |
| HRP20231146T1 (hr) | 2018-07-11 | 2024-01-05 | Aquanova Ag | Solubilizat ksantohumola |
| KR20210042949A (ko) * | 2018-08-10 | 2021-04-20 | 산토리 홀딩스 가부시키가이샤 | 혈당치 상승 억제용 조성물 및 혈당치 상승 억제 방법 |
| AU2019319292A1 (en) * | 2018-08-10 | 2021-02-04 | Suntory Holdings Limited | Composition for promoting uric acid excretion, composition for inhibiting URAT1 and composition for lowering blood uric acid level |
| EP3834625A4 (en) * | 2018-08-10 | 2022-05-04 | Suntory Holdings Limited | AGENT FOR SUPPRESSING MICROBIAL GROWTH, METHOD FOR PREVENTING MICROBIAL CONTAMINATION, AND BEVERAGE |
| AU2019320346A1 (en) * | 2018-08-10 | 2021-01-28 | Suntory Holdings Limited | Composition for improving intestinal environment and method for improving intestinal flora |
| WO2022173750A1 (en) * | 2021-02-09 | 2022-08-18 | Oregon State University | Xanthohumol derivatives and methods for making and using |
| CA3225379A1 (en) * | 2021-07-09 | 2023-01-12 | Devrim ARAN | Prenylated chalcone and flavonoid compositions for use in treating cancer |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07285856A (ja) | 1994-04-21 | 1995-10-31 | Hoechst Japan Ltd | 骨粗鬆症治療剤 |
| RU2232016C2 (ru) * | 1996-08-30 | 2004-07-10 | эНПиэС ФАМЭСЬЮТИКЭЛС, ИНК. | Изовалерамид-антиспастическое и противосудорожное средство, экстракт из растения семейства valerianaceae или хмеля - средство для лечения симптома спастичности и способ устранения этого симптома, способ лечения патологии, снимаемой центрально-опосредованным снижением мышечного тонуса |
| AU6174900A (en) | 1999-07-08 | 2001-01-30 | Patrick T. Prendergast | Use of flavones, coumarins and related compounds to treat infections |
| JP3293601B2 (ja) * | 1999-09-03 | 2002-06-17 | 松下電器産業株式会社 | 管球およびその製造方法 |
| WO2001076614A1 (en) * | 2000-04-10 | 2001-10-18 | Takara Bio Inc. | Remedies |
| BR0208418A (pt) * | 2001-04-05 | 2004-03-30 | Unilever Nv | Uso de isoxantohumol e/ou xantohumol, método para administrar isoxantohumol e/ou xantohumol a seres humanos em necessidade de receber um componente ani-inflamatório ou anti-envelhecimento, e, produto alimentìcio |
| EP1415657A4 (en) * | 2001-07-13 | 2005-09-14 | Takara Bio Inc | DRUG |
| DE10308864B4 (de) | 2003-02-28 | 2007-03-01 | Paulaner Brauerei Gmbh & Co. Kg | Neues Brauverfahren, damit gebrautes Bier und dessen Verwendung |
| EP1543834A1 (en) | 2003-12-16 | 2005-06-22 | Biodynamics | Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| US20060276372A1 (en) * | 2005-03-09 | 2006-12-07 | Lockwood Samuel F | Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders |
| JP2006306800A (ja) * | 2005-04-28 | 2006-11-09 | Kirin Brewery Co Ltd | ファルネソイドｘ受容体活性化剤 |
| KR20080063748A (ko) * | 2005-07-29 | 2008-07-07 | 바이오액티브스, 인코포레이티드 | 프레닐플라보노이드 제형 |
| AU2006280074A1 (en) * | 2005-08-09 | 2007-02-22 | Metaproteomics, Llc | Protein kinase modulation by hops and acacia products |
| JP5246834B2 (ja) * | 2005-12-27 | 2013-07-24 | 独立行政法人産業技術総合研究所 | アディポネクチン産生強化剤 |
-
2006
- 2006-12-22 DE DE102006062264A patent/DE102006062264A1/de not_active Ceased
-
2007
- 2007-12-21 EP EP20070857069 patent/EP2120906B1/de not_active Not-in-force
- 2007-12-21 RU RU2009128213/15A patent/RU2454996C2/ru not_active IP Right Cessation
- 2007-12-21 US US12/520,756 patent/US20100029757A1/en not_active Abandoned
- 2007-12-21 WO PCT/EP2007/011358 patent/WO2008077618A1/de not_active Ceased
- 2007-12-21 JP JP2009541912A patent/JP5513126B2/ja not_active Expired - Fee Related
- 2007-12-21 CA CA2672155A patent/CA2672155C/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010513360A5 (enExample) | ||
| JP2012520866A5 (enExample) | ||
| JP5513126B2 (ja) | 肝疾患を予防および／または制御するための、キサントフモールまたはイソキサントフモールの活性物質としての使用 | |
| JP2011519364A5 (enExample) | ||
| JP2011068653A5 (enExample) | ||
| JP2006515883A5 (enExample) | ||
| JP2018507914A5 (enExample) | ||
| JP2009102342A5 (enExample) | ||
| JP2015524444A5 (enExample) | ||
| JP2010522698A5 (enExample) | ||
| JP2014530874A5 (enExample) | ||
| JP2013505233A5 (enExample) | ||
| JP2013518124A5 (enExample) | ||
| FI3884947T3 (fi) | Lääkkeen hyötyosuuden lisääminen naltreksonihoidossa | |
| JP2009513713A5 (enExample) | ||
| JP2011510922A5 (enExample) | ||
| JP2002528502A5 (enExample) | ||
| WO2011159100A2 (ko) | 항암 활성을 나타내는 약제학적 조성물 | |
| JP2006518731A5 (enExample) | ||
| WO2005065429B1 (en) | Composition and method for treatment of hepatic encephalopathy | |
| CN101932322A (zh) | 用于治疗丙型肝炎病毒感染的包含HMG-CoA还原酶抑制剂和胆汁酸的药物组合物 | |
| JP2008540506A5 (enExample) | ||
| WO2012042197A3 (en) | Low dose pharmaceutical composition comprising zanamivir | |
| JP2009506043A5 (enExample) | ||
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 |